Get started today

Safety of Medicinal Cannabis

Presented by Associate Professor Ali Seyfoddin.

About this module:

In this presentation, Associate Professor Ali Seyfoddin gives a summary of the safety aspects of cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD) including common side effects, drug-cannabis interactions, and contraindications. He also explores some of the scientific evidence of safety of cannabis in the treatment of specific illnesses, as well as safety in relation to long-term use. 

This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Learning Outcomes

At the end of this module, learners will be able to:

  • Describe the potential side effects of cannabis (and tetrahydrocannabinol).
  • Describe the potential side effects of cannabidiol (CBD).
  • Assess the potential for interactions between medicinal cannabis products and pharmaceuticals.
  • Discuss potential contraindications for the use of medicinal cannabis.
  • Debate the level of scientific evidence of safety of cannabis for a range of clinical conditions.
MEET THE INSTRUCTOR

Assoc Prof. Ali Seyfoddin

Dr Ali Seyfoddin is the Deputy Head of School of Science at Auckland University of Technology. Trained as a pharmacist, he leads the Drug Delivery Research Group (www.drugdelivery.aut.ac.nz) and his research interests are primarily pharmaceutical formulation, biological engineering and bioprospecting.

Being practically minded, he finds application for his research in natural drug discovery, nanoencapsulation, 3D- and bio-printing, aquaculture feed technology and medicinal cannabis (cultivation, processing, extraction and formulation). He also teaches a range of undergraduate and postgraduate courses related to pharmacology, biomedical sciences and medicinal cannabis science.

Featured links

Connect with us

Created with